Filing Details

Accession Number:
0001209191-10-053843
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-09 09:22:54
Reporting Period:
2010-11-05
Filing Date:
2010-11-09
Accepted Time:
2010-11-09 09:22:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1003642 Impax Laboratories Inc IPXL Pharmaceutical Preparations (2834) 650403311
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1336015 Christopher Mengler C/O Impax Laboratories, Inc.
30831 Huntwood Avenue
Hayward CA 94544
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-11-05 7,460 $19.32 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 100 shares at $19.22; 700 shares at $19.24; 200 shares at $19.25; 1,600 shares at $19.27; 100 shares at $19.28; 310 shares at $19.29; 300 shares at $19.31; 100 shares at $19.33; 100 shares at $19.34; 1,200 shares at $19.35; 600 shares at $19.36; 700 shares at $19.37; 700 shares at $19.38; and 750 shares at $19.40.